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Ulla Beijer, Achim Wolf, Seena Fazel
Summary
Background 100 million people worldwide are homeless; rates of mortality and morbidity are high in this population. 
The contribution of infectious diseases to these adverse outcomes is uncertain. Accurate estimates of prevalence data 
are important for public policy and planning and development of clinical services tailored to homeless people. We 
aimed to establish the prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people.
Methods We searched PubMed, Embase, and Cumulative Index to Nursing and Allied Health Literature for studies of 
the prevalence of tuberculosis, hepatitis C virus, and HIV in homeless populations. We also searched bibliographic 
indices, scanned reference lists, and corresponded with authors. We explored potential sources of heterogeneity in 
the estimates by metaregression analysis and calculated prevalence ratios to compare prevalence estimates for 
homeless people with those for the general population.
Findings We identiﬁ ed 43 eligible surveys with a total population of 63 812 (59 736 homeless individuals when 
duplication due to overlapping samples was accounted for). Prevalences ranged from 0·2% to 7·7% for tuberculosis, 
3·9% to 36·2% for hepatitis C virus infection, and 0·3% to 21·1% for HIV infection. We noted substantial heterogeneity 
in prevalence estimates for tuberculosis, hepatitis C virus infection, and HIV infection (all Cochran’s χ² signiﬁ cant at 
p<0·0001; I²=83%, 95% CI 76–89; 95%, 94–96; and 94%, 93–95; respectively). Prevalence ratios ranged from 34 to 
452 for tuberculosis, 4 to 70 for hepatitis C virus infection, and 1 to 77 for HIV infection. Tuberculosis prevalence was 
higher in studies in which diagnosis was by chest radiography than in those which used other diagnostic methods and 
in countries with a higher general population prevalence than in those with a lower general prevalence. Prevalence of 
HIV infection was lower in newer studies than in older ones and was higher in the USA than in the rest of the world.
Interpretation Heterogeneity in prevalence estimates for tuberculosis, hepatitis C virus, and HIV suggests the need 
for local surveys to inform development of health services for homeless people. The role of targeted and population-
based measures in the reduction of risks of infectious diseases, premature mortality, and other adverse outcomes 
needs further examination. Guidelines for screening and treatment of infectious diseases in homeless people might 
need to be reviewed.
Funding The Wellcome Trust.
Introduction
An estimated 100 million people worldwide are home-
less.1 In high-income countries, country-speciﬁ c data 
sug gest that more than 650 000 individuals in the USA2 
and around 380 000 in the UK3 are homeless at any one 
time. Although most live in sheltered accommodation—
eg, emergency hostels, bed and breakfasts, squats, or 
other temporary accommodation—a 2011 US report2 has 
estimated that 39% of homeless people are unsheltered, 
and thus roughly 250 000 individuals live on the streets, 
more than 120 000 of whom are in the New York City and 
Los Angeles metropolitan areas.2 Although methodo-
logical diﬃ  culties exist in counting homeless people and 
deﬁ nitions of homelessness vary, these estimates help to 
quantify the number of homeless people.4
Health problems in homeless populations have been 
previously reported.5,6 Mortality rates are four times higher 
than in the general population.7 Morbidity is substantially 
increased in homeless populations, who have higher 
prevalences of mental disorders8 and infectious diseases 
than do general populations,6 which, being modiﬁ able, 
could be targeted by health interventions to reduce the 
frequency of adverse outcomes. Infections in homeless 
people can lead to community infections and are associated 
with malnutrition,9 long periods of homelessness,10 and 
high use of medical services.11 Because absolute numbers 
of homeless people are high in some countries, 
improvements in care could have pronounced eﬀ ects on 
public health.
A wide range of estimates for the prevalence of infec-
tious diseases in homeless people have been reported, 
particularly for tuberculosis, hepatitis C virus, and HIV.12 
A synthesis of these prevalence data would be important 
for public policy and planning and development of clinical 
services addressing the needs of homeless people. It could 
also inform future projects by identifying methodological 
problems and research priorities.
We did a systematic review and metaregression analysis 
to establish the prevalence of tuberculosis, hepatitis C 
virus, and HIV in homeless people. We explored by 
metaregression the reasons for variations between the 
primary studies and examined whether prevalence varied 
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by year of publication, sex, study region, diagnostic 
method, and study size.
Methods
Search strategy and selection criteria
We searched PubMed, Embase, and Cumulative Index to 
Nursing and Allied Health Literature with the term 
“homeless* and (tuberculosis or HIV or hepatitis C or 
HCV)” for studies of the prevalences of tuberculosis and 
hepatitis C virus and HIV infections in homeless people 
published between Jan 1, 1980, and Jan 31, 2012. We 
focused on these diseases after preliminary searches 
showed many reports estimating their prevalences and 
reviews emphasising their importance.6,12 We also 
searched relevant reference lists and relevant journals by 
hand and corresponded with authors. We translated non-
English-language articles. Our analyses accorded with 
the preferred reporting items for systematic reviews and 
meta-analyses (PRISMA) guidelines (when appropriate) 
for a systematic review of prevalences.13
Studies had to meet two criteria for inclusion. They had 
to investigate adults with no ﬁ xed abode (owned or 
rented), who rely on temporary accommodation, live in 
institutions or shelters, or live rough (in a context where 
most peers have homes and homelessness is not because 
of war, conﬂ ict, or natural disasters), and had to present 
data that allowed for establishment of prevalences of 
tuberculosis, hepatitis C virus, and HIV. Investigations 
were included irrespective of diagnostic methods, but 
mostly included chest radiography for tuberculosis and 
blood tests for hepatitis C virus, and HIV. Diagnoses 
based on questionnaires (ie, self-report of disease status) 
were also included.
We excluded reports if the number of homeless 
individuals was not reported separately from the number 
of non-homeless people and could not be obtained from 
the authors; prevalences of infectious diseases were 
grouped and not available separately for tuberculosis, 
hepatitis C virus, and HIV; the methods were unclear; or 
the study population was homeless drug users only (drug 
use is a major risk factor for infection with HIV and 
hepatitis C virus,12 and prevalence would therefore not be 
representative of homeless populations). Bucher and 
colleagues’ study14 investigated both homeless people and 
individuals who live in single-room occupancies. 
However, we included only the homeless subgroup in 
our analysis—we did not deem those in single-room 
occupancy homeless.
Two reviewers (Anna Francis [Oxford University Medical 
School, Oxford, UK] and UB for most studies; AW and UB 
for the remainder) independently extracted information 
about geographical location, year of publication, deﬁ nition 
of homelessness, duration of homelessness, risk factors 
for homelessness, method of sample selection, sample 
Country Sex Sampling method Diagnostic 
method
Mean 
age
n
Glicksman et al,38 1984 USA Male Homeless men in one shelter for men and two hotels in New York City, 
NY
Unknown ·· 198
Barry et al,9 1986 USA Male Homeless men in three large shelters in Boston, MA during four nights Chest radiography ·· 465
Capewell et al,37 1986 UK Male Adult homeless men in eight hostels or shelters in Edinburgh, Scotland Chest radiography ·· 2150
Ramsden et al,44 1988 UK Mixed Two centres for homeless people in London Chest radiography ·· 555
Kumar et al,42 1995 UK Male All homeless people in a shelter in London Chest radiography 41 557
Kimerling et al,41 1999 USA Male Homeless men in two shelters in Birmingham, AL Sputum 41 127
Southern et al,47 1999 UK Male Homeless adults in hostels, night shelters, and day centres for homeless 
in London
Chest radiography ·· 1905
Moss et al, 43 2000* USA Mixed Homeless adults from free food lines and shelters in San Francisco, CA Sputum 38 2764
Zunic et al,49 2000 France Mixed Homeless adults in shelters in Paris Chest radiography ·· 663
Solsona et al,46 2001 Spain Male Homeless people admitted to shelters for homeless people or soup 
kitchens, or both
Chest radiography ·· 394
Kern et al,40 2005 France Mixed Homeless adults in shelters in Paris Chest radiography ·· 204
Romaszko et al,45 2008† Poland Mixed Social service workers were trained to reach out to homeless people Chest radiography ·· 305
Badiaga et al,35 2009‡ France Male All homeless people in two shelters in Marseilles Chest radiography 41 208
Beijer et al,36 2009§ Sweden Mixed All homeless adults (in shelters, temporary accommodations, etc) who 
were documented as homeless in 1996
Unknown 34 1704
McAdam et al,20 2009 USA Male Eight shelters and drop-in centres in New York City, NY Unknown 43 28 835
Tabuchi et al,48 2011 Japan Male Homeless people associated with the shelter and soup-run in Airin 
district, Osaka
Chest radiography 58 263
Goetsch et al,39 2012 Germany Mixed Homeless people in shelters or facilities for homeless people in Frankfurt Chest radiography 41 2308
*HIV infection and being older than 50 years were positively associated with prevalence; use of injection drugs, crack cocaine, or alcohol was not signiﬁ cantly associated with 
prevalence. †67% of participants were homeless for greater than 3 years. ‡Participants were homeless for <6 months (43%), 7–12 months (12%), 13–24 months (9%), or 
>24 months (36%). §Participants’ sex was not signiﬁ cantly associated with prevalence.
Table 1: Studies of the prevalence of tuberculosis in homeless people
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size, mean age, diagnostic method, diagnostic criteria, 
and numbers diagnosed with tuberculosis, hepatitis C 
virus, or HIV from every eligible study. Disagreement was 
resolved by consensus between the two reviewers or 
through consultation with the corresponding author, 
when necessary. If needed, we sought further clariﬁ cations 
from the authors of relevant studies.
Statistical analysis
We calculated prevalence estimates with the variance-
stabilising double arcsine transformation,15 because the 
inverse variance weight in ﬁ xed-eﬀ ects meta-analyses is 
suboptimum when dealing with binary data with low 
prevalences. Additionally, the transformed prevalences are 
weighted very slightly towards 50%, and studies with 
prevalences of zero can thus be included in the analysis. 
We used the Wilson method16 to calculate 95% CIs around 
these estimates because the asymptotic method produces 
intervals which can extend below zero.17 We estimated 
heterogeneity between studies with Cochran’s Q (reported 
as χ² and p values) and the I² statistic, which describes the 
percentage of variation between studies that is due to 
heterogeneity rather than chance.18,19 Unlike Q, I² does not 
inherently depend on the number of studies included; 
values of 25%, 50%, and 75% show low, moderate, and 
high degrees of hetero geneity, respectively. Because 
heterogeneity was high (I² >75%), we used random-eﬀ ects 
models for summary statistics.19 These models (in which 
the individual study weight is the sum of the weight used 
in a ﬁ xed-eﬀ ects model and between-study variability) 
produce study weights that mainly show between-study 
variation and thus provide close to equal weighting. In our 
analyses, we split study populations into male and female 
groups as appropriate. We deﬁ ned studies as mixed when 
only overall estimates of the prevalences of infection were 
reported and we could not obtain further information 
Country Sex Sampling method Inclusion criteria Diagnostic 
method
Mean 
age
n Length of 
homelessness
Risk factors
Rosenblum 
et al,55 2001
USA Mixed Homeless people in contact with 
mobile clinic, Manhattan, New York 
City, NY
Homeless, 21–58 years 
old
Blood 40 139 ·· Use of injection drugs was positively 
associated with prevalence
Nyamathi 
et al,54 2002
USA Female Derived from a large study of 
homeless women in shelters and on 
the streets, Los Angeles, CA
Homeless, 18–65 years 
old, having an intimate 
partner or friend willing 
to participate
Blood ·· 884 ·· Use of injection drugs was positively 
associated with prevalence
Sherriﬀ  
et al,56 2003
UK Mixed Homeless people from shelters, 
special projects, and medical centres 
in Oxford
Homeless adults Oral ﬂ uid ·· 98 ·· Use of injection drugs and sharing of drug 
paraphernalia were positively associated 
with prevalence; age, needle sharing, 
alcohol, sexual activity, family history of 
hepatitis C virus infection, tattoos, and 
piercings were not signiﬁ cantly associated
Beijer,50 
2007
Sweden Mixed All homeless people in contact with 
the Social Services Unit for 
Homeless People in Stockholm
Homeless adults Blood 42 2285 ·· ··
Brito et al,52 
2007
Brazil Mixed Homeless adults who use shelters, 
São Paulo, Brazil
Homeless adults aged 
18 years or older 
without psychiatric 
disturbances who use 
shelters
Blood 40 330 <1 year (39%), 
>5 years (13%)
Use of injection drugs, sharing of drug 
paraphernalia, and previous imprisonment 
were positively associated with prevalence
Burström 
et al,21 2007
Sweden Mixed Homeless adults in shelters and 
institutions and rough sleepers in 
Stockholm
Homeless adults Questionnaire 48 155 >10 years 
(40%)
··
O’Carroll 
et al,22 2008
Ireland Male All homeless people living in 
temporary accommodation in 
Dublin
Homeless adults in 
hostels and bed and 
breakfasts
Questionnaire ·· 343 ·· ··
Schwarz 
et al,58 2008
USA Female Homeless families or caregivers with 
children in shelters and transitional 
houses, Baltimore City, MD
Homeless adults or 
caregivers with children
Blood ·· 161 ·· ··
Boyce et al,51 
2009
USA Mixed Homeless shelter in Honolulu, HI Homeless people in a 
shelter
Blood 39 40 ·· ··
Vahdani 
et al,59 2009
Iran Male Homeless people in institutions of 
the municipal authorities, shelter 
homeless, and rough sleepers in 
Tehran
Homeless, in a shelter Blood 45 202 Mean 502 days 
(range 
10–3700)
··
Colson 
et al,53 2011
France Male Two homeless shelters in Marseilles Homeless adults Blood 41 220 ·· ··
Stein et al,57 
2011
USA Mixed Homeless people in shelters and 
meal programmes, Los Angeles, CA
Homeless adults Blood ·· 534 ·· ··
Table 2: Studies of the prevalence of hepatitis C virus infection in homeless people
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from the authors to stratify results by sex. In a subgroup 
analysis, we calculated the prevalences of tuberculosis, 
hepatitis C, and HIV for US and European studies to 
provide estimates for high-income countries and to allow 
comparison with studies of prevalence done in prisoners 
in those geographical regions. We did three sensitivity 
analyses; we excluded one large study20 from the 
tuberculosis group and, for both hepatitis C virus21,22 and 
HIV infections,21–27 we looked only at studies of prevalence 
that used blood samples for diagnosis.
We did an additional analysis that compared the preva-
lences in homeless people with estimated prevalences in 
the general population to calculate prevalence ratios and 
95% CIs. Information about the prevalence of 
tuberculosis and HIV infection in the general population 
was obtained from the UN Millen nium Development 
Goals Database.28,29 For hepatitis C virus infection, we 
used country-speciﬁ c estimates from US and European 
studies.30,31 We obtained denominator (total population) 
data from the UN World Population Prospects Database.32 
We chose the national data that most closely matched the 
year of publication of the study.
Heterogeneity
We further investigated potential sources of hetero-
geneity by arranging groups of studies according to 
potentially relevant characteristics and by metaregression 
analysis, which attempts to relate diﬀ erences in eﬀ ect 
sizes to study characteristics.33 Factors exam ined both 
individually and in multiple-variable models were year of 
publication, sex (by comparing mixed-sex samples with 
single-sex samples), geographical region (by comparing 
USA-based studies with those based elsewhere), study 
size (by comparing investigations of more than 
Country Sex Sampling method Inclusion criteria Diagnostic 
method
Mean 
age
n Length of 
homelessness
Risk factors
Zolopa 
et al,10 1994
USA Mixed Random sampling from shelters and 
soup kitchens in San Francisco, CA
Homeless adults older than 
18 years
Blood 36 1226 Median 12 months 
in men, 6 months 
in women (range 
1 day–40 years)
Injection drug use, black race, 
homosexuality, and sex work 
were positively associated 
with prevalence; age was not 
signiﬁ cantly associated
Paris et al,64 
1996
USA Mixed Homeless people in contact with mobile 
outreach team in Atlanta, GA
Homeless, in contact with 
a mobile outreach team or 
clinic
Blood ·· 535 ·· ··
Magura 
et al,63 2000
USA Mixed Homeless men and women from two 
soup kitchens in New York City, NY
Homeless adults Blood ·· 191 ·· ··
Rosenblum 
et al,55 2001
USA Mixed Homeless people in contact with mobile 
clinic, Manhattan, New York City, NY
Homeless, 21–58 years old Blood 40 139 ·· ··
Nyamathi 
et al,54 2002
USA Female Derived from a large study of homeless 
women in shelters and on the streets, 
Los Angeles, CA
Homeless, 18–65 years old, 
having an intimate partner 
or friend willing to 
participate
Blood ·· 884 ·· ··
Herndon 
et al,25 2003
USA Female Homeless women in shelters and soup 
kitchens in Los Angeles, CA
Homeless women in 
shelters and soup kitchen
Questionnaire 33 970 ·· ··
Hahn et al,62 
2004
USA Mixed Homeless people in shelters, free meal 
programmes, and hostels, San Francisco, 
CA
Homeless adults Blood ·· 799 ·· ··
Robertson 
et al,65 2004
USA Mixed Homeless people from shelters, free meal 
programmes, and hotels, San Francisco, 
CA
Homeless adults Blood 42 2508 ·· Injection drug use, being male, 
and white race were positively 
associated with prevalence; 
being older than 30 years was 
negatively associated
Brouqui 
et al,60 2005
France Mixed All homeless adults in two shelters in 
Marseilles
Homeless adults in shelters Blood 43 889 ·· ··
Grimley 
et al,61 2006
USA Male All homeless adults in three shelters in 
two cities
Homeless adults Oral ﬂ uid 35 285 ·· ··
Beijer,50 
2007
Sweden Mixed All homeless people in contact with the 
Social Services Unit for Homeless People 
in Stockholm
Homeless adults Blood 42 2285 ··
Brito et al,52 
2007
Brazil Mixed Homeless adults who use shelters, 
São Paulo
Homeless adults aged 
18 years or older without 
psychiatric disturbances 
who use shelters
Blood 40 330 <1 year (39%), 
>5 years (13%)
··
Bucher 
et al,14 2007
USA Mixed Homeless people from all homeless 
shelters and free meal programmes in 
San Francisco, CA
Homeless adults Blood ·· 681 >1 year (69%) ··
(Continues on next page)
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Country Sex Sampling method Inclusion criteria Diagnostic 
method
Mean 
age
n Length of 
homelessness
Risk factors
(Continued from previous page)
Burström 
et al,21 2007
Sweden Mixed Homeless people in shelters and 
institutions and rough sleepers in 
Stockholm
Homeless adults Questionnaire 48 155 >10 years (40%) ··
Forney 
et al,24 2007
USA Mixed Homeless people in shelters and soup 
kitchens in San Francisco, CA
Homeless adults Questionnaire 42 218 ·· ··
Talukdar 
et al,66 2007
India Male Homeless men living in public space in 
30 days in Kolkata
Homeless men aged 
18–49 years
Blood 28 493 ·· Circumcision was negatively 
associated with prevalence
O’Carroll 
et al,22 2008
Ireland Mixed All homeless people living in temporary 
accommodation in Dublin
Homeless adults in hostels 
and bed and breakfasts
Questionnaire ·· 345 ·· ··
Vahdani 
et al,59 2009
Iran Male Homeless people in institutions of the 
municipal authorities, shelter homeless, 
and rough sleepers in Tehran
Homeless, in a shelter Blood 45 202 Mean 502 days 
(range 10–3700)
··
Fogg et al,23 
2010
USA Mixed Homeless people from shelters in the six 
states in New England
Homeless adults Questionnaire ·· 316 ·· ··
Laporte 
et al,26 2010
France Mixed Homeless shelters in Paris Homeless adults Questionnaire ·· 840 Mean 8·5 years in 
men and 4·3 years 
in women
··
Wenzel 
et al,27 2011
USA Male Homeless men from meal programmes 
in Skid Row area of Los Angeles, CA
Homeless heterosexually 
active men
Questionnaire ·· 305 ·· Having an HIV-positive 
partner or several partners was 
positively associated with 
prevalence
Colson 
et al,53 2011
France Male Two homeless shelters in Marseilles Homeless adults Blood 41 220 ·· ··
Table 3: Studies of the prevalence of HIV infection in homeless people
Figure 1: Estimated prevalence of tuberculosis in homeless people
Weights are from random-eﬀ ects analysis. For the mixed and female samples, shading represents, and is proportional to, study weight.
Male
Glicksman et al, 1984
Barry et al, 1986
Capewell et al, 1986
Ramsden et al, 1988
Kumar et al, 1995
Southern et al, 1999
Kimerling et al, 1999
Moss et al, 2000
Solsona et al, 2001
Romaszko et al, 2008
Beijer et al, 2009
McAdam et al, 2009
Badiaga et al, 2009
Goetsch et al, 2012
Tabuchi et al, 2011
Subtotal (I²=87%, p<0·0001)
Female
Ramsden et al, 1988
Moss et al, 2000
Romaszko et al, 2008
Beijer et al, 2009
Goetsch et al, 2012
Subtotal (I²=0%, p=0·579)
Mixed
Zunic et al, 2000
Kern et al, 2005
Subtotal (I²=0%, p=0·336)
0·05 (0·03–0·09)
0·01 (0·00–0·02)
0·03 (0·02–0·04)
0·01 (0·00–0·02)
0·02 (0·01–0·03)
0·01 (0·00–0·01)
0·04 (0·01–0·08)
0·01 (0·01–0·02)
0·01 (0·01–0·03)
0·02 (0·01–0·05)
0·00 (0·00–0·01)
0·00 (0·00–0·00)
0·01 (0·00–0·04)
0·01 (0·01–0·02)
0·02 (0·01–0·04)
0·01 (0·01–0·02)
0·08 (0·02–0·29)
0·01 (0·00–0·02)
0·03 (0·01–0·14)
0·00 (0·00–0·02)
0·02 (0·01–0·04)
0·01 (0·00–0·01)
0·01 (0·01–0·03)
0·03 (0·01–0·06)
0·02 (0·01–0·02)
 1·41
 7·27
 8·42
 7·04
 5·89
 10·59
 1·15
 10·09
 5·29
 3·18
 10·97
 11·54
 3·58
 9·99
 3·59
 100·00
 0·15
 55·67
 0·66
 34·81
 8·71
 100·00
 86·25
 13·75
 100·00
0 0·05 0·1
Prevalence estimate (95% CI)    weight (%) 
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500 individuals with smaller studies, and additionally 
through use of sample size as a continuous variable), 
diagnostic method (by comparing studies that diagnosed 
tuberculosis by chest radiography with reports that used 
other methods, and studies that used blood analysis for 
diagnosis of HIV or hepatitis C virus infections with 
those that diagnosed by other methods), and estimates of 
prevalence in the general population of the study country 
(as a continuous variable). These factors were selected on 
the basis of previous work about hetero geneity in 
prevalence studies in homeless people.34 We entered only 
factors that we deemed signiﬁ cant individually (p<0·05) 
into a multiple regression model to avoid model 
instability. The regression coeﬃ  cients for each study 
characteristic on individual analysis were provided to 
enable comparison across diagnoses. We did all analyses 
in Stata (version 12·1) with the commands metan (for 
random-eﬀ ects meta-analysis specifying three variables: 
double-arcsine-transformed prevalence, Wilson CIs, and 
prevalence ratios) and metareg (for metaregression).
Role of the funding source
The Wellcome Trust had no role in study design, data 
collection, analysis, interpretation, or writing of the report. 
All authors had full access to the study data and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Our searches returned a total of 4024 records (appendix). 
After removal of duplicates and initial screening, we 
reviewed 210 papers in full. After exclusion of ineligible 
reports, our ﬁ nal sample was 43 studies (n=63 812) 
published between December, 1984, and Jan 12, 2012, 
including 17 studies (43 605) of tuberculosis9,20,35–49 
(table 1), 12 (5391) of hepatitis C21,22,50–59 (table 2), and 
22 (14 816) of HIV10,14,21–27,50,52–55,59–66 (table 3). After taking 
into account duplication of patients because of 
overlapping samples, the overall population consisted of 
59 736 homeless individuals.
Of the 17 reports for tuberculosis, ten included data 
for men (n=35 102);9,20,35,37,38,41,42,46–48 the other seven were 
mixed-sex samples (8503).36,39,40,43–45,49 In the surveys with 
mixed-sex samples, 83% of participants were men 
(weighted average). Five reports were from the USA 
(n=32 389),9,20,38,41,43 four from the UK (5167),37,42,44,47 three 
from France (1075),35,40,49 and one each from Ger many39 
(2308),39 Sweden (1704),36 Spain (394),46 Poland (305),45 and 
Japan (263).48 Tuberculosis was diagnosed by chest 
radiography in 12 studies9,35,37,39,40,42,44–49 (9977) and by 
sputum culture in two41,43 (2891); the method of diagnosis 
was unknown in the remaining three (30 737).20,36,38 
Estimates of tuberculosis prevalence ranged from 
0·2% to 7·7% (ﬁ gure 1); heterogeneity was substantial 
(χ²=126, p<0·0001; I²=83%, 95% CI 76–89). The random-
eﬀ ects pooled prevalence was 1·1% (95% CI 0·8–1·5). In 
individual variable metaregression analysis, the 
prevalence of tuberculosis was higher in studies in which 
chest radiography was used for diagnosis (p=0·047) than 
in those in which other diagnostic methods were used; 
high general population prevalence was related to high 
prevalence in homeless people (p=0·039; table 4), but the 
relation did not remain signiﬁ cant after multivariate 
metaregression.
Three reports in men (n=765),22,53,59 two in women 
(1045),54,58 and seven in mixed-sex samples (3581) included 
data for hepatitis C virus infection.21,50–52,55–57 77% of 
participants in mixed-sex samples were men (weighted 
average). Five reports were from the USA (1758),51,54,55,57,58 two 
from Sweden (2440),21,50 and one each from Ireland (343),22 
Brazil (330),52 France (220),53 Iran (202),59 and the UK 
(98).56 Diagnosis of hepatitis C virus infection was based 
on blood analyses in nine of the investigations (4795),50–55,57–
59 questionnaires in two (498),21,22 and PCR analysis of oral 
ﬂ uids in one (98).56 Prevalence ranged from 3·9% to 
36·2% (ﬁ gure 2), with substantial heterogeneity between 
the estimates (χ²=354, p<0·0001; I²=95%, 95% CI 94–96). 
The random-eﬀ ects pooled prevalence of hepatitis C virus 
infection was 20·3% (95% CI 15·5–25·2). None of the 
factors we explored further was signiﬁ cantly associated 
with heterogeneity on metaregression (table 4).
Of the 22 reports for HIV infection, ﬁ ve had data for 
men (n=1505),27,53,59,61,66 two for women (1854),25,54 and 
15 for mixed-sex samples (11 457).10,14,21–24,26,50,52,55,60,62–65 In the 
surveys with mixed-sex samples, 69% of individuals were 
Metaregression 
coeﬃ  cient (%)
95% CI p
Tuberculosis
Year of publication –0·04 –0·08 to 0·01 0·065
Sex (male vs female) –0·11 –0·80 to 0·58 0·739
Country (USA vs other) –0·33 –1·22 to 0·56 0·452
Diagnosis (chest radiography vs other) 0·74 0·01 to 1·47 0·047
Sample size (>500 vs ≤500) 0·76 –0·13 to 1·66 0·091
Sample size, continuous –0·0004 –0·00009 to 0·001 0·139
Population prevalence (per 100 000) 0·05 0·003 to 0·11 0·039
Hepatitis C virus
Year of publication –1·20 –3·07 to 0·67 0·191
Sex (male vs female) –1·01 –10·68 to 8·65 0·827
Country (USA vs other) 2·29 –9·08 to 14·87 0·615
Diagnosis (blood test vs other) –11·94 –24·49 to 0·61 0·061
Sample size (>500 vs ≤500) 1·88 –11·69 to 15·45 0·773
Sample size, continuous –0·04 –0·11 to 0·09 0·509
Population prevalence (per 100 000) 0·003 –0·006 to 0·01 0·444
HIV
Year of publication –0·34 –0·66 to –0·02 0·037
Sex (male vs female) –0·80 –3·11 to 1·51 0·488
Country (USA vs other) 3·18 –0·19 to 6·16 0·038
Diagnosis (blood test vs other) 1·51 –1·88 to 4·89 0·371
Sample size (>500 vs ≤500) 1·90 –1·26 to 5·06 0·229
Sample size, continuous 0·00007 –0·03 to 0·04 0·969
Population prevalence (per 100 000) 0·002 –0·01 to 0·01 0·640
Table 4: Univariate metaregression for prevalences of tuberculosis, hepatitis C virus, and HIV in homeless 
people
See Online for appendix
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men (weighted average). 13 studies were from the USA 
(9057),10,14,23–25,27,54,55,61–65 three from France (1949),26,53,60 two 
from Sweden (2440),21,50 and one each from India (493),66 
Ireland (345),22 Brazil (330),52 and Iran (202).59 HIV was 
diagnosed on the basis of blood analyses in 14 reports 
(11 382),10,14,50,52–55,59,60,62–65 question naires in seven (3149),21–27 
and PCR analysis of saliva in one  (285).61
Estimates of the prevalence of HIV infection ranged 
from 0·3% to 21·1% (ﬁ gure 3); heterogeneity was 
pronounced (χ²=541, p<0·0001; I²=94%, 95% CI 93–95). 
The random-eﬀ ects pooled prevalence was 4·7% (95% CI 
3·6–5·8). In univariate metaregression analyses, older 
studies had higher prevalences than did newer studies 
(p=0·037), and prevalence was higher in studies from the 
USA (p=0·038) than in those from the rest of the world 
(appendix); however, these ﬁ ndings did not remain 
signiﬁ cant after multivariate metaregression.
Prevalences of tuberculosis and hepatitis C and HIV 
infection in US and European studies seemed similar to 
overall prevalences, although no statistical comparisons 
were done. For tuberculosis (excluding a study from 
Japan48), estimates ranged from 0·2% to 7·7%, with 
substantial heterogeneity (χ²=123, p<0·0001; I²=84%, 
95% CI 76–89). The random-eﬀ ects pooled prevalence 
was 1·1% (95% CI 0·8–1·4). For hepatitis C virus 
infection (excluding a study from Brazil52 and another 
from Iran59), estimates ranged from 4·3% to 36·2%, with 
substantial heterogeneity (χ²=296, p<0·0001; I²=95%, 
95% CI 94–97). The random-eﬀ ects pooled prevalence 
was: 21·4% (95% CI 15·9–26·8). For HIV infection 
(excluding studies from Brazil,52 India,66 and Iran59), 
estimates ranged from 0·3% to 21·1%; heterogeneity was 
substantial (χ²=524, p<0·0001; I²=95%, 95% CI 93–96). 
The random-eﬀ ects pooled prevalence was 4·8% (95% CI 
3·6–6·0). Use of arcsine-transformed estimates of 
prevalence made little diﬀ erence to the overall random-
eﬀ ects estimates, which were themselves shown to be 
notably diﬀ erent (closer to 50%) from the ﬁ xed-eﬀ ects 
estimates (in which smaller prevalences have smaller 
SEs and thus greater weight than they would have in 
random-eﬀ ects estimates).
As part of our sensitivity analyses, we excluded one large 
tuberculosis study;20 the prevalences did not change, 
whereas the random-eﬀ ects pooled prevalence rose slightly 
to 1·2% (95% CI 0·8–1·6). For infection with hepatitis C 
virus, when two studies were excluded in which diagnosis 
was based on questionnaires21,22 and a third in which it was 
based on analysis of oral ﬂ uid,56 estimates of prevalence 
ranged from 3·9% to 35·3% with substantial heterogeneity 
(χ²=257, p<0·0001; I²=95·3%, 95% CI 93·5–96·7). When 
we excluded these studies, the random-eﬀ ects pooled 
prevalence fell to 17·5% (95% CI 12·4–22·5). For HIV 
infection, when seven questionnaire studies21–27 and one 
study based on analysis of oral ﬂ uid61 were excluded, 
estimates of prevalence ranged from 0·3% to 21·1% with 
substantial heterogeneity (χ²=494, p<0·0001; I²=95·7%, 
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Figure 2: Estimated prevalence of hepatitis C virus infection in homeless people
Weights are from random-eﬀ ects analysis. For the mixed study, shading represents, and is proportional to, study weight.
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95% CI 94·6–96·7). The random-eﬀ ects pooled preva lence 
increased to 5·4% (95% CI 3·9–6·8).
Prevalence ratios ranged from 34 to 452 for tuberculosis 
(ﬁ gure 4), 4 to 70 for hepatitis C virus infection (ﬁ gure 5), 
and 1 to 77 for HIV infection (ﬁ gure 6). Heterogeneity 
was substantial in all cases (I²>80%).
Discussion
Our systematic review and meta-analysis of tuberculosis, 
hepatitis C virus, and HIV prevalences in homeless 
people identiﬁ ed 43 studies of 59 736 individuals. Our 
main ﬁ nding was that, of these three infectious diseases, 
hepatitis C virus infection had the highest prevalence in 
homeless populations and tuberculosis the lowest. 
Additionally, we noted substantial heterogeneity between 
studies, suggesting the need for locally based studies to 
inform service planning and public health measures.
The main implication of our results is that the 
identiﬁ cation and management of infections should be 
integral to the planning and development of services for 
homeless people, which is further emphasised by the risks 
of contagion to the rest of the community. 2012 clinical 
guidelines from the UK National Institute for Health and 
Clinical Excellence67 showed that screening and treatment 
of tuberculosis is cost saving (£20 000 [US$32 000] per 
quality-adjusted life year) in homeless populations with a 
tuberculosis prevalence of 0·25% or higher. 15 of 17 studies 
in our systematic review had higher prevalences than this 
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Figure 3: Estimated prevalence of HIV infection in homeless people
Weights are from random-eﬀ ects analysis. For the mixed studies, shading represents, and is proportional to, study weight. *The point for the prevalence estimate is 
outside the range of the graph.
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cutoﬀ , sug gesting that universal screening of homeless 
populations should be considered. True prevalence could 
be higher still, because subclinical tuberculosis cannot be 
detected by chest radiography (used in at least 12 of the 
17 studies included), the use of which is partly dependent 
on patients presenting with clinical symp toms.68 By 
contrast, the true prevalence of hepatitis C virus could be 
lower than that established in our study because positive 
serology can also be an indicator of past infection. 
However, both past and active infections are potentially 
infective69 and therefore carry a public health risk.
Our heterogeneity analyses generated several poten tially 
important ﬁ ndings. For tuberculosis, chest radiography 
was associated with signiﬁ cantly higher prevalence than 
were other diagnostic methods. This ﬁ nding might be 
because of the lower sensitivity of sputum analysis 
compared with chest radiography.68 Prevalence of 
tuberculosis in homeless people was positively associated 
with prevalence in the general population, but this relation 
did not hold for hepatitis C virus and HIV. This result is 
potentially important from a public health perspective 
because it suggests that general population measures to 
reduce rates of hepatitis C virus and HIV infections might 
not translate into lower prevalences in homeless people. 
Older studies and those from the USA showed signiﬁ cantly 
higher prevalences of HIV infection than did newer 
studies and those from elsewhere. The substantial 
heterogeneity for all three infections suggests that caution 
is necessary when pooled estimates are used and 
emphasises the need for careful description of samples 
and diagnostic methods in surveys. However, for hepatitis 
C virus and HIV infections, our sensitivity analyses 
showed that our overall results were not materially 
diﬀ erent when we included only studies in which diagnosis 
was blood based. Characteristics that we did not test might 
have been associated with heterogeneity, such as length of 
homelessness or age at onset of homelessness, and future 
research should describe samples in further detail.
Previous reviews of infectious diseases in homeless 
people include a 2001 narrative review,12 and a 
2011 systematic re view30 of hepatitis C virus infection in 
the USA that reported a higher prevalence than that in 
our review because it included selected populations of 
homeless people—eg, those with co-occurring HIV 
infection or other medical illnesses and those who 
misuse substances.
We did not limit studies by country in our inclusion 
criteria. All but four studies were done in Europe or the 
USA, showing the need for further research in low-
income and middle-income countries (some of which 
will be undergoing rapid urbanisation). Of the 43 studies 
included in our systematic review, only eight include 
prevalence estimates for more than one of the diseases 
that we investigated. An important limitation of our work 
is that we did not include other infections because our 
initial scoping search did not identify many relevant 
studies and we wanted to focus on the infections that 
arguably have the largest eﬀ ect on public health. High 
rates of infection with hepatitis A and B viruses, 
diphtheria, and inﬂ uenza have been reported in homeless 
people.12 Furthermore, a narrative review by Raoult and 
col leagues12 has shown the morbidity associated with foot 
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Figure 4: Prevalence ratios of tuberculosis in homeless people versus same-country general populations
Figure 5: Prevalence ratios of hepatitis C virus infection in homeless people versus same-country general 
populations
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problems and skin infections—eg, scabies, body lice, and 
louse-transmitted infections. Further research should 
assess other infectious diseases, especially if these 
additional investigations have little cost.
Another limitation is that our systematic review is 
based on cross-sectional designs, and therefore infer-
ences about causality cannot be made. However, several 
included studies reported risk factor information, and 
the role of injection drug use should be examined further. 
We did not identify any longitudinal studies, which 
would be practically diﬃ  cult but important for future 
research because they would provide information on the 
development of infectious diseases and especially risk 
factors and mediators.
Prevalence ratios suggest that, in the USA, 
tuberculosis is at least about 46 times more common in 
homeless than in general populations; the prevalence 
of hepatitis C virus infection is increased about four 
times. Prevalence ratios were also increased for the 
HIV studies, but not to the same extent. These ratios 
contrast with the prevalence data, in which hepatitis C 
virus infection typically has the highest absolute rates 
of infection. A more direct comparison than these 
prevalence ratios would be studies that use the same 
sampling methods, diagnostic approaches, and inter-
viewers that are used to estimate prevalences in the 
homeless sample to establish prevalences of infection 
in a general population sample; we only identiﬁ ed one 
such study.36
Prevalences in homeless people could be compared 
with those in other high-risk groups within the 
same geographical regions—eg, prisoners. Incarcerated 
people have increased rates of morbidity and mortality, 
especially for infectious diseases,70 and targeted inter-
ventions could have substantial public health eﬀ ects.71 
Mean rates of tuberculosis were higher in homeless 
people than in prisoners, in whom notiﬁ cation rates for 
tuberculosis are reported to vary from 0 to 1167 per 
100 000.72 Similarly high rates have been reported for 
hepatitis C virus infection, with studies of seropositivity 
from 14 countries showing antibodies to hepatitis C virus 
in 2–58% of prisoners and typical rates of 30–40%.73 
Estimates of the prevalence of HIV infection in prisoners 
in high-income countries range from 0% to 7·5%, and in 
the USA, prevalence was estimated at 1·5% in 2007–08.70,74 
Few comparative data exist for prisoners in low-income 
and middle-income countries.75
Many people transition between prison and being 
homeless,76 suggesting sizeable overlap between these 
estimates. 2012 National Institute for Health and Clinical 
Excellence guidelines67 recommend that these 
marginalised groups should be screened simultaneously 
for tuberculosis, hepatitis C virus, and HIV, and, when 
necessary, patients should be helped to over come barriers 
to completing screening and treatment, such as 
transport, housing, nutrition, and immigration status.67
Screening for tuberculosis should be done through 
active case-ﬁ nding—ie, should not be restricted to 
symptomatic people presenting to health services, 
which happens less and later in marginalised groups 
than in general populations.67 Other measures, 
including syr inge and needle exchange programmes, 
free condom distribution, and treatment of related 
infections (particularly scabies,77 body lice,78 and louse-
borne infections60) have been recommended.79 Yearly 
snapshot interventions,60 inpatient treatment of speciﬁ c 
infections because of the risk of non-adherence, and 
ﬁ rst-aid centres in large cities should be considered.12 
Whenever possible, screening should follow best-
practice guide lines; diagnosis should be based on chest 
radiography and analysis of oral ﬂ uid for tuberculosis80 
and blood-based testing for hepatitis C virus69 and HIV.81 
In addition to these targeted measures, reduction of the 
inequalities faced by homeless people in overall social 
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Figure 6: Prevalence ratio of HIV infection in homeless people versus same-country general populations
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determinants of health could be part of a wider public 
health strategy to address infections in some countries.82 
Other population-based approaches might include 
housing policies83 and equal access to health care.84
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